Pharmaceuticals

Suven Life to unveil new drug candidates at US neuroscience meet

12 Nov 2010

Ranbaxy registers 168 per cent leap in end-Sept profit

12 Nov 2010

Arthritis drugs could help prevent memory loss after surgery, study suggests

09 Nov 2010

Eli Lilly's $800-mn Avid deal boosts diagnostic capabilities

09 Nov 2010

Privately held Avid is a developer of new molecular imaging agents that aid medical management of chronic human diseases

HCL Technologies enters clinical research market in Australia with Novotech deal

08 Nov 2010

US drug distributor McKesson to acquiire US Oncology in $2.16 billion deal

02 Nov 2010

World's first mechanical LVAD transplant performed

02 Nov 2010

The world's first lifesaving heart machine, left ventricular assisted device (LVAD), was successfully fitted to a patient by Dr. Jack Copeland, professor of surgery and director of cardiac transplantation and mechanical circulatory support at UC San Diego Health System

Drug controller brings in new rules to curb antibiotics abuse

30 Oct 2010

Merck KGaA sells women’s health business to Teva for €285 million

30 Oct 2010

Researchers moot proton therapy as future cancer treatment

30 Oct 2010

Biocon to invest $161 million in Malaysian biotech firm

28 Oct 2010

New vaccine holds promise of polio-free future

27 Oct 2010

GlaxoSmithKline to pay $750 mn to settle US adulterated drugs lawsuit

27 Oct 2010

Strides' generic oseltamivir receives WHO prequalification for treatment of H1N1

26 Oct 2010

Dr Reddy's expands sales in Russia & CIS through licensing deals

25 Oct 2010

Lancet's malarial estimation methodology suspect says WHO

23 Oct 2010

Malaria kills 2 lakh in India every year: Lancet report

22 Oct 2010

Pfizer buys 40-% stake in Brazilian generics firm Teuto for $240 million

20 Oct 2010

Cipla launches first generic pirfenidone in India

20 Oct 2010

No standard for placebos in drug trials

By By Debra Kain | 19 Oct 2010

Pfizer, Biocon enter into deal for biosimilar insulin

19 Oct 2010

Hyderabad research firm announces India’s first cell-cultured H1N1 swine flu vaccine

18 Oct 2010

Pfizer to buy pain drug company King Pharma for $3.6 billion

12 Oct 2010

King develops, manufactures and markets therapies and technologies in specialty-driven markets, including neuroscience, hospital and acute care medicines.

Top global pharma players in fray for Paras

12 Oct 2010

ImmunoGen to collaborate with Novartis on novel cancer treatment

12 Oct 2010